IRVINE, CA--(Marketwire - June 03, 2009) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the world’s leading dental laser company, announced today that CEO David M. Mulder is scheduled to make an investor presentation at the 8th Annual Needham Life Sciences Conference on Thursday, June 11, at 10:00 am Eastern Time. The conference is being held June 10-11, at the New York Palace in New York City.
The presentation will be accessible by live webcast on the Investors section of the BIOLASE website at www.biolase.com. A replay of the webcast will be available on the BIOLASE website for 30 days.
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc. (http://www.biolase.com), the world’s leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company’s products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE’s principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
For further information, please contact:
Jill Bertotti
Allen & Caron
+1-949-474-4300
